High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Chumsri, Saranya, Sperinde, Jeff, Liu, Heshan, Gligorov, Joseph, Spano, Jean-Philippe, Antoine, Martine, Moreno Aspitia, Alvaro, Tan, Winston, Winslow, John, Petropoulos, Christos J, Chenna, Ahmed, Bates, Michael, Weidler, Jodi Marie, Huang, Weidong, Dueck, Amylou, Perez, Edith A
Published in Clinical cancer research (01.07.2018)
Published in Clinical cancer research (01.07.2018)
Get full text
Journal Article
Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
GHOSH, Ritwik, NARASANNA, Archana, SPERINDE, Jeff, DUA, Rajiv, PIDAPARTHI, Sailaja, MUKHERJEE, Ali, LEITZEL, Kim, KOSTLER, Wolfgang J, LIPTON, Allan, BATES, Michael, ARTEAGA, Carlos L, WANG, Shizhen Emily, SHUYING LIU, CHAKRABARTY, Anindita, BALKO, Justin M, GONZALEZ-ANGULO, Ana Maria, MILLS, Gordon B, PENUEL, Elicia, WINSLOW, John
Published in Cancer research (Chicago, Ill.) (01.03.2011)
Published in Cancer research (Chicago, Ill.) (01.03.2011)
Get full text
Journal Article
p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial
Sperinde, Jeff, Huang, Weidong, Vehtari, Aki, Chenna, Ahmed, Kellokumpu-Lehtinen, Pirkko-Liisa, Winslow, John, Bono, Petri, Lie, Yolanda S, Petropoulos, Christos J, Weidler, Jodi, Joensuu, Heikki
Published in Clinical cancer research (01.07.2018)
Published in Clinical cancer research (01.07.2018)
Get full text
Journal Article
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
Lipton, Allan, Goodman, Laurie, Leitzel, Kim, Cook, Jennifer, Sperinde, Jeff, Haddad, Mojgan, Köstler, Wolfgang J., Huang, Weidong, Weidler, Jodi M., Ali, Suhail, Newton, Alicia, Fuchs, Eva-Marie, Paquet, Agnes, Singer, Christian F., Horvat, Reinhard, Jin, Xueguang, Banerjee, Joyee, Mukherjee, Ali, Tan, Yuping, Shi, Yining, Chenna, Ahmed, Larson, Jeff, Lie, Yolanda, Sherwood, Thomas, Petropoulos, Christos J., Williams, Stephen, Winslow, John, Parry, Gordon, Bates, Michael
Published in Breast cancer research and treatment (01.08.2013)
Published in Breast cancer research and treatment (01.08.2013)
Get full text
Journal Article
Correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2+ Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy
Duchnowska, Renata, Biernat, Wojciech, Szostakiewicz, Barbara, Sperinde, Jeff, Piette, Fanny, Haddad, Mojgan, Paquet, Agnes, Lie, Yolanda, Czartoryska‐Arłukowicz, Bogumiła, Wysocki, Piotr, Jankowski, Tomasz, Radecka, Barbara, Foszczyńska‐Kłoda, Małgorzata, Litwiniuk, Maria, Dȩbska, Sylwia, Weidler, Jodi, Huang, Weidong, Buyse, Marc, Bates, Michael, Jassem, Jacek
Published in The oncologist (Dayton, Ohio) (01.01.2012)
Published in The oncologist (Dayton, Ohio) (01.01.2012)
Get full text
Journal Article
Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2
Mamluk, Roni, Carvajal, Irvith M., Morse, Brent A., Wong, Henry K, Abramowitz, Janette, Aslanian, Sharon, Lim, Ai-Ching, Gokemeijer, Jochem, Storek, Michael J., Lee, Joonsoo, Gosselin, Michael, Wright, Martin C., Camphausen, Ray T., Wang, Jack, Chen, Yan, Miller, Kathy, Sanders, Kerry, Short, Sarah, Sperinde, Jeff, Prasad, Gargi, Williams, Stephen, Kerbel, Robert S., Ebos, John, Mutsaers, Anthony, Mendlein, John D., Harris, Alan S., Furfine, Eric S.
Published in mAbs (01.03.2010)
Published in mAbs (01.03.2010)
Get full text
Journal Article
Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
Toi, Masakazu, Sperinde, Jeff, Huang, Weidong, Saji, Shigehira, Winslow, John, Jin, Xueguang, Tan, Yuping, Ohno, Shinji, Nakamura, Seigo, Iwata, Hiroji, Masuda, Norikazu, Aogi, Kenjiro, Morita, Satoshi, Petropoulos, Christos, Bates, Michael
Published in BMC cancer (23.02.2010)
Published in BMC cancer (23.02.2010)
Get full text
Journal Article
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10
Abraham, Jame, Montero, Albert J, Jankowitz, Rachel C, Salkeni, Mohamad Adham, Beumer, Jan H, Kiesel, Brian F, Piette, Fanny, Adamson, Laura M, Nagy, Rebecca J, Lanman, Richard B, Sperinde, Jeff, Huang, Weidong, Allegra, Carmen J, Srinivasan, Ashok, Wang, Ying, Pogue-Geile, Katherine L, Lucas, Peter C, Jacobs, Samuel A
Published in Journal of clinical oncology (10.10.2019)
Published in Journal of clinical oncology (10.10.2019)
Get full text
Journal Article
p95HER2-T cell bispecific antibody for breast cancer treatment
Rius Ruiz, Irene, Vicario, Rocio, Morancho, Beatriz, Morales, Cristina Bernadó, Arenas, Enrique J, Herter, Sylvia, Freimoser-Grundschober, Anne, Somandin, Jitka, Sam, Johannes, Ast, Oliver, Barriocanal, Águeda Martinez, Luque, Antonio, Escorihuela, Marta, Varela, Ismael, Cuartas, Isabel, Nuciforo, Paolo, Fasani, Roberta, Peg, Vicente, Rubio, Isabel, Cortés, Javier, Serra, Violeta, Escriva-de-Romani, Santiago, Sperinde, Jeff, Chenna, Ahmed, Huang, Weidong, Winslow, John, Albanell, Joan, Seoane, Joan, Scaltriti, Maurizio, Baselga, Jose, Tabernero, Josep, Umana, Pablo, Bacac, Marina, Saura, Cristina, Klein, Christian, Arribas, Joaquín
Published in Science translational medicine (03.10.2018)
Published in Science translational medicine (03.10.2018)
Get more information
Journal Article
High HER2 expression correlates with response to the combination of lapatinib and trastuzumab
Scaltriti, Maurizio, Nuciforo, Paolo, Bradbury, Ian, Sperinde, Jeff, Agbor-Tarh, Dominique, Campbell, Christine, Chenna, Ahmed, Winslow, John, Serra, Violeta, Parra, Josep Lluis, Prudkin, Ludmila, Jimenez, José, Aura, Claudia, Harbeck, Nadia, Pusztai, Lajos, Ellis, Catherine, Eidtmann, Holger, Arribas, Joaquin, Cortes, Javier, de Azambuja, Evandro, Piccart, Martine, Baselga, José
Published in Clinical cancer research (01.02.2015)
Published in Clinical cancer research (01.02.2015)
Get full text
Journal Article
Quantitative measurement of total erbB2 (H2T), p110 t-erbB2, and erbB2:erbB3 (H23D) heterodimer expression and p110 t-erbB2 in malignant progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)
Zong, Yu, Shen, Kunwei, Sperinde, Jeff, Wallweber, Gerald, Huang, Weidong, Winslow, John William, Liang, Wenchuan, Pegram, Mark D.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients
SPERINDE, Jeff, XUEGUANG JIN, FUCHS, Eva-Maria, SINGER, Christian F, KÖSTLER, Wolfgang J, BATES, Michael, PARRY, Gordon, WINSLOW, John, LIPTON, Allan, BANERJEE, Jayee, PENUEL, Elicia, SAHA, Anasuya, DIEDRICH, Gundo, WEIDONG HUANG, LEITZEL, Kim, WEIDLER, Jodi, ALI, Suhail M
Published in Clinical cancer research (15.08.2010)
Published in Clinical cancer research (15.08.2010)
Get full text
Journal Article
Clinical performance of the beta‐amyloid 1‐42/1‐40 ratio determined from automated Lumipulse G1200 cerebrospinal fluid Abeta1‐42 and Abeta1‐40 assays, assessed by concordance with PET imaging status
Winslow, John W., Martone, Robert L., Badal, Youssouf W., Chenna, Ahmed W., Cai, Suqin W, Sperinde, Jeff W., Ayonke, Jeric W., Vergara, Jamie, Yee, Brandon W., Spiro, Lisa W., Ozegovich, Terri, Nisenbaum, Laura, Petropoulos, Christos W.
Published in Alzheimer's & dementia (01.12.2021)
Published in Alzheimer's & dementia (01.12.2021)
Get full text
Journal Article
Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer
Rigakos, Georgios, Razis, Evangelia, Koliou, Georgia-Angeliki, Oikonomopoulos, Georgios, Tsolaki, Eleftheria, Sperinde, Jeff, Chrisafi, Sofia, Zarkavelis, George, Pazarli, Elissavet, Batistatou, Anna, Kourea, Helen P, Papakostas, Pavlos, Bafaloukos, Dimitrios, Asimakopoulou, Natalia I, Res, Eleni, Kotsakis, Athanasios, Pectasides, Dimitrios, Koutras, Angelos, Christodoulou, Christos, Fountzilas, George
Published in Anticancer research (01.04.2021)
Published in Anticancer research (01.04.2021)
Get full text
Journal Article
HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant
Growdon, Whitfield B, Groeneweg, Jolijn, Byron, Virginia, DiGloria, Celeste, Borger, Darrell R, Tambouret, Rosemary, Foster, Rosemary, Chenna, Ahmed, Sperinde, Jeff, Winslow, John, Rueda, Bo R
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival
Yardley, Denise A, Kaufman, Peter A, Huang, Weidong, Krekow, Lea, Savin, Michael, Lawler, William E, Zrada, Stephen, Starr, Alexander, Einhorn, Harvey, Schwartzberg, Lee S, Adams, John W, Lie, Yolanda, Paquet, Agnes C, Sperinde, Jeff, Haddad, Mojgan, Anderson, Steve, Brigino, Marlon, Pesano, Rick, Bates, Michael P, Weidler, Jodi, Bosserman, Linda
Published in Breast cancer research : BCR (18.03.2015)
Published in Breast cancer research : BCR (18.03.2015)
Get full text
Journal Article
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
Montemurro, Filippo, Prat, Aleix, Rossi, Valentina, Valabrega, Giorgio, Sperinde, Jeff, Peraldo-Neia, Caterina, Donadio, Michela, Galván, Patricia, Sapino, Anna, Aglietta, Massimo, Baselga, José, Scaltriti, Maurizio
Published in Molecular oncology (01.02.2014)
Published in Molecular oncology (01.02.2014)
Get full text
Journal Article
Quantitative Measurements of Tumoral p95HER2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab: Independent Validation of the p95HER2 Clinical Cutoff
DUCHNOWSKA, Renata, SPERINDE, Jeff, CZARTORYSKA-ARLUKO-WICZ, Bogumiła, WYSOCKI, Piotr J, FOSZCZYNSKA-KŁODA, Małgorzata, RADECKA, Barbara, LITWINIUK, Maria M, ZOK, Jolanta, WISNIEWSKI, Michał, ZUZIAK, Dorota, BIERNAT, Wojciech, JASSEM, Jacek, CHENNA, Ahmed, HADDAD, Mojgan, PAQUET, Agnes, LIE, Yolanda, WEIDLER, Jodi M, WEIDONG HUANG, WINSLOW, John, JANKOWSKI, Tomasz
Published in Clinical cancer research (15.05.2014)
Published in Clinical cancer research (15.05.2014)
Get full text
Journal Article
Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization‐positive patients with metastatic breast cancer treated with trastuzumab
Lipton, Allan, Köstler, Wolfgang J., Leitzel, Kim, Ali, Suhail M., Sperinde, Jeff, Weidler, Jodi, Paquet, Agnes, Sherwood, Thomas, Huang, Weidong, Bates, Michael
Published in Cancer (15.11.2010)
Published in Cancer (15.11.2010)
Get full text
Journal Article
Abstract LB-292: p95HER2-T cell bispecific antibody for breast cancer treatment
Vicario, Rocío, Ruiz, Irene Rius, Morancho, Beatriz, Morales, Cristina Bernadó, Herter, Sylvia, Freimoser-Grundscholber, Anne, Somandin, Jitka, Sam, Johannes, Ast, Oliver, Barriocanal, Águeda Martinez, Luque, Antonio, Escorihuela, Marta, Varela, Ismael, Nuciforo, Paolo, Fasani, Roberta, Peg, Vicente, Rubio, Isabel, Cortés, Javier, Serra, Violeta, Escrivá, Santiago, Sperinde, Jeff, Chenna, Ahmed, Huang, Weidong, Winslow, John, Scaltriti, Maurizio, Baselga, Josep, Tabernero, Josep, Umaña, Pablo, Bacac, Marina, Saura, Cristina, Klein, Christian, Arribas, Joaquín
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article